Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 9, 2007, Pages 659-661

  Soriano, A ^a   Bregada, E ^a   Marques J M ^a   Ortega, M ^a   Bove A ^a   Martinez J A ^a   Mensa, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANALYSIS OF VARIANCE; ARTICLE; CATHETER; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DIALYSIS CATHETER; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; SYRINGE; TURBIDIMETRY;

ANTI-BACTERIAL AGENTS; ATTENTION; CATHETERS, INDWELLING; HEMODIAFILTRATION; HUMANS; VANCOMYCIN;

EID: 34548142255     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0356-7     Document Type: Article

References (13)

1. Carratala J (2002) The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clin Microbiol Infect 8:282-289
2. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A (1999) The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771-1776
3. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E (2003) Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47:3145-3148
4. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G et al (2007) Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51:1656-1660
5. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D et al (2006) Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57:1172-1180
6. Haimi-Cohen Y, Husain N, Meenan J, Karayalcin G, Lehrer M, Rubin LG (2001) Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother 45:1565-1567
7. Robinson JL, Tawfik G, Saxinger L, Stang L, Etches W, Lee B (2005) Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy. J Antimicrob Chemother 56:951-953
8. Anthony TU, Rubin LG (1999) Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 43:2074-2076
9. Capdevila JA, Segarra A, Planes AM, Ramirez-Arellano M, Pahissa A, Piera L et al (1993) Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 8:231-234
10. Bailey E, Berry N, Cheesbrough JS (2002) Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J Antimicrob Chemother 50:615-617
11. Berrington A, Gould FK (2001) Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 48:597-603
12. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE (2005) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55:90-94
13. Lee JY, Ko KS, Peck KR, Oh WS, Song JH (2006) In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 57:1110-1115